Role of Home Monitoring in Reducing Disparities in the Interstage Mortality of Infants with Single Ventricle

Yousef El-Magharbel1, Caren S Goldberg2, Sunkyung Yu2

  • 1Congenital Heart Center, C. S. Mott Children's Hospital, Ann Arbor, MI.

Insights

The interstage home monitoring program (IHMP) improved survival and growth for single ventricle (SV) patients after the Norwood procedure. However, sociodemographic disparities in outcomes persist, indicating a need for targeted interventions for vulnerable populations.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Research
  • Health Services Research

Background:

  • Single ventricle (SV) physiology presents complex challenges in pediatric cardiac surgery.
  • The interstage period (between Norwood and stage 2 palliation) is critical for SV patient outcomes.
  • Disparities in survival and growth among SV patients necessitate targeted monitoring programs.

Purpose of the Study:

  • To evaluate the impact of an interstage home monitoring program (IHMP) on disparities in interstage survival and growth.
  • To assess the effectiveness of IHMP in mitigating clinical and sociodemographic factors affecting outcomes.
  • To analyze changes in interstage mortality (ISM) and interstage growth (ISG) post-IHMP implementation.

Main Methods:

  • Retrospective single-center study of SV patients undergoing the Norwood operation (2000-2020).
  • Data sourced from electronic medical records, PC4 and NPC-QIC registries, and US census.
  • Multivariable logistic and linear regressions analyzed IHMP's effect on ISM and ISG, controlling for clinical and sociodemographic variables using the NEONATE risk score.

Main Results:

  • Interstage mortality (ISM) decreased significantly post-IHMP (12.7% vs 6.7%, P=0.04).
  • Average interstage growth (ISG) z-scores improved significantly post-IHMP (-0.15 vs 0.14, P=0.01).
  • Lower birthweight, public insurance, and high NEONATE risk score remained independently associated with adverse ISM and ISG, even after IHMP adjustment.

Conclusions:

  • The IHMP has demonstrably improved interstage growth and survival for single ventricle patients.
  • Despite improvements, significant sociodemographic disparities in outcomes persist.
  • A tailored approach is crucial to address the needs of vulnerable SV patient groups and reduce persistent disparities.
Abstract